Attached files
| file | filename |
|---|---|
| EX-99.1 - REMEDENT, INC. | v228801_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 15, 2011
REMEDENT, INC.
(Exact name of Registrant as Specified in its Charter)
|
Nevada
(State or Other Jurisdiction of
Incorporation)
|
001-15975
(Commission File Number)
|
86-0837251
(IRS Employer
Identification No.)
|
|
BelgiumZuiderlaan 1-3 bus 8, 9000 Ghent, Belgium
(Address of Principal Executive Offices)
|
N/A
(Zip Code)
|
011-329-321-7080
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Section 2 – Financial Information
Item 2.02 Results of Operations and Financial Condition.
On July 15, 2011, the Company issued a press release reporting its financial results for the year and fourth quarter ended March 31, 2011, and announcing a conference call to discuss the results on Tuesday, July 19, 2011, at 7:00 a.m Eastern time (10:00 a.m. Pacific time).
A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Section 7 – Regulation FD
Item 7.01. Regulation FD Disclosure
On July 15, 2011, the Company issued a press release reporting its financial results for the year and quarter ended March 31, 2011, and announcing conference call to discuss the financial results and plans for the remainder of the fiscal year, including efforts to focus resources on expansion in China, and reduce corporate overhead expenses, on Tuesday, July 19, 2011, at 7:00 a.m Eastern time (10:00 a.m. Pacific time).
A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No.
|
Exhibit Description
|
|
|
99.1
|
Press Release dated July 15, 2011
|
The information set forth under Items 2.02 and 7.01 of this Form 8-K and Exhibit 99.1 attached hereto are furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, and shall not be deemed incorporated by reference in any filing with the Securities and Exchange Commission under the Securities Exchange Act of 1934 or the Securities Act of 1933, whether made before or after the date hereof and irrespective of any general incorporation by reference language in any filing.
Portions of this report constitute “forward-looking statements” defined by federal law. Although the Company believes any such statements are based on reasonable assumptions, there is no assurance that the actual outcomes will not be materially different. Any such statements are made in reliance on the “safe harbor” protections provided under the Private Securities Litigation Reform Act of 1995. Additional information about issues that could lead to material changes in the Company’s performance is contained in the Company’s filings with the Securities and Exchange Commission and may be accessed at www.sec.gov.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
REMEDENT, INC.,
|
|||
|
a Nevada corporation
|
|||
|
Dated: July 15, 2011
|
By:
|
/s/ Stephen Ross
|
|
|
Stephen Ross
Chief Financial Officer
|
|||
3